Six months’ treatment with MIV-711, a novel Cathepsin K...

Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial

Conaghan, P.G., Bowes, M.A., Kingsbury, S.R., Brett, A., Guillard, G., Tunblad, K., Rizoska, B., Larsson, T., Holmgren, Å., Manninen, A., Göhlin, K., Heber, W., Graham, P., Jansson, Å., Wadell, C., Be
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Osteoarthritis and Cartilage
DOI:
10.1016/j.joca.2018.02.066
Date:
April, 2018
File:
PDF, 258 KB
english, 2018
Conversion to is in progress
Conversion to is failed